Compare ATYR & RMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATYR | RMR |
|---|---|---|
| Founded | 2005 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.2M | 253.9M |
| IPO Year | 2015 | N/A |
| Metric | ATYR | RMR |
|---|---|---|
| Price | $0.78 | $15.74 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $8.75 | N/A |
| AVG Volume (30 Days) | ★ 2.6M | 197.5K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 11.44% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | $190,000.00 | ★ $196,824,000.00 |
| Revenue This Year | N/A | $301.43 |
| Revenue Next Year | $18,728.88 | N/A |
| P/E Ratio | ★ N/A | $15.28 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.64 | $13.48 |
| 52 Week High | $7.29 | $22.22 |
| Indicator | ATYR | RMR |
|---|---|---|
| Relative Strength Index (RSI) | 43.35 | 57.29 |
| Support Level | $0.70 | $14.85 |
| Resistance Level | $0.83 | $15.77 |
| Average True Range (ATR) | 0.06 | 0.36 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 57.87 | 80.40 |
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.